Novo Nordisk’s shock decision to oust its chief executive has resulted in the Ozempic maker once again becoming Europe’s ...

The U.S.-listed shares of Danish drugmaker Novo Nordisk rose Tuesday following a report that an activist investor is building ...

At least 10 hospital executives from Nassau University Medical Center, including its CEO, have put in their resignations in response to what they called a “hostile takeover” by Gov.

Investors flocked to shares of NRG as the energy supplier boosted capacity. UnitedHealth stock slumped, and the company’s CEO resigned.

From Novo Nordisk to UnitedHealth, former chief executives are returning to guide their former organization in times of trouble.

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren ...

Stellantis has today announced the appointment of Antonio Filosa as the company’s CEO, a position that has been conspicuously vacant following the unexpected resignation of founding chief ...

Novo Nordisk's sharp 54% decline is driven ... will divert significant prescription volume to NVO's products. The CEO's resignation is a short-term destabilizing and unsettling development for ...

Global pressures and a leadership change Novo Nordisk's CEO, Lars Fruergaard Jørgensen ... market share against Wegovy and Ozempic. The resignation was described as a mutual decision between ...

President Trump threatened to levy a new 50% tariff on E.U.-imported goods last week. Novo Nordisk manufactures much of its GLP-1 drugs in Denmark. The president delayed implementation of the ...